Thursday, March 9, 2023

Evofem Biosciences Swizzles CFO

San Diego-based Evofem Biosciences said this morning that it has named Albert Altro as the company's new interim Chief Financial Officer, replacing current CFO Jay File. The company said that File is leaving the company to "explore other opportunities". Evofem says that Altro focuses on servicing primarily middle market privately held corporations, as well as debtors-in-possession, secured and unsecured creditors, private equity groups and strategic buyers. The company said Altro will assist the company as it explores "options to build shareholder value." Evofem has been trading OTCBB since being delisted from the Nasdaq in August of 2022.